Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study

Conditions:   Philadelphia-Negative ALL;   High-Risk Cancer Intervention:   Drug: Blinatumomab Sponsor:   Israeli Medical Association Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials